Month: January 2021

Innofactor Plc Inside Information, on January 29, 2021, at 16:35 Finnish timeInnofactor and a Norwegian financial services company have signed an agreement concerning the migration and implementation of services to Microsoft Azure. The solution will be built on the Innofactor Virtual Data Center solution.The value of the agreement (excluding VAT) is approximately EUR 500,000 and the services will be delivered during the year 2021.Espoo, January 29, 2021INNOFACTOR PLCSami Ensio, CEOAdditional information:Sami Ensio, CEOInnofactor PlcTel. +358 50 584 2029sami.ensio@innofactor.comDistribution:NASDAQ HelsinkiMain mediawww.innofactor.comInnofactorInnofactor is the leading provider of modern digital organization for companies, public administration and third sector for its over 1,500 customers in the Nordic countries. Innofactor has the widest...

Brilacidin treatment unlikely to be impacted by coronavirus variants, such as those originating in the U.K., South Africa and Brazil, and spreading worldwide, due to its ability to attack the virus directlyWAKEFIELD, Mass., Jan. 29, 2021 (GLOBE NEWSWIRE) — Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, announces today that the Company’s Phase 2 clinical trial of Brilacidin for treating COVID-19 is scheduled to begin next week.The Phase 2 randomized, placebo-controlled clinical trial is to include approximately 120 hospitalized patients with moderate-to-severe COVID-19. Two intravenous treatment arms are to be enrolled—active and placebo, with ~60 patients per arm. The trial’s primary endpoint is time to sustained recovery through Day 29 based on the National Institute of Allergy...

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and the Article 223-16 of the Règlement général de l’Autorité des marchés financiers (Regulation of the French stock market authority)                 Company name of the issuer:                      Renault SA13/15 quai Alphonse Le Gallo92100 Boulogne-Billancourt(ISIN code FR0000131906 – RNO) (1) Number calculated on the basis of all shares to which voting rights are attached, including shares for which voting rights cannot be exercised, according to Article 223-11 of the Règlement général de l’Autorité des marchés financiers.(2) Number of voting rights exercisable at general meetings is equal to the theoretical number of voting rights (total number of voting rights attached...

Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8-II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des marchés financiersDénomination sociale de l’émetteur :          Renault SA13/15 quai Alphonse Le Gallo92100 Boulogne-Billancourt(code ISIN FR0000131906 – RNO)(1) Nombre calculé sur la base de l’ensemble des actions auxquelles sont attachés des droits de vote, y compris les actions privées de droit de vote, conformément à l’article 223-11 du Règlement général de l’Autorité des marchés financiers.(2) Nombre de droits de vote exerçables en assemblée générale = nombre de droits de vote théoriques (nombre total de droits de vote attachés aux actions) – droits de vote attachés aux actions privées du droit de vote.Pièce jointe12 – 31 décembre 2020 –...

ATHENS, Greece, Jan. 29, 2021 (GLOBE NEWSWIRE) — Growth Capital Acquisition Corp. (NASDAQ: GCACU) (“Growth Capital” or the “Company”) today announced the pricing of its initial public offering of 15,000,000 units at a price of $10.00 per unit. The units are expected to begin trading on the Nasdaq Capital Market (“Nasdaq”) on January 29, 2021 under the symbol “GCACU”. Each unit consists of one share of Class A common stock and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one share of Class A common stock at a price of $11.50 per share. Only whole warrants are exercisable. Once the securities comprising the units begin separate trading, the shares of Class A common stock and warrants are expected to be traded on the Nasdaq under the symbols “GCAC” and “GCACW,”...

Dr. Tyan Will Lead and Advance Organ Transplantation Therapeutic ProgramMountain View, CA, Jan. 29, 2021 (GLOBE NEWSWIRE) —  via NewMediaWire— Aditx Therapeutics, Inc. (Aditxt) (the “Company”) (Nasdaq: ADTX), a biotech innovation company developing biotechnologies specifically focused on improving the health of the immune system through immune monitoring and reprogramming, today announced the appointment of Dr. Dolly B. Tyan as Senior Vice President of Clinical Development – Transplantation. In this role, Dr. Tyan will be overseeing Aditxt’s therapeutic program for organ rejection including advancing current candidates towards clinical trials and developing new products for new applications.  Dr. Tyan’s career of over 45 years prior to joining Aditxt was devoted to nine solid organ and two bone marrow/stem cell transplant...

San Diego, California, Jan. 29, 2021 (GLOBE NEWSWIRE) — Tesoro Enterprises, Inc. (OTCMKT: TSNP), which will soon be renamed HUMBL, Inc., announced today the launch of its new collection on HUMBL Studios, called HUMBL x SHOP. The online shop will offer affordable HUMBL clothing and merchandise for supporters of the HUMBL brand, as well as further memorabilia and collectibles.“We have been receiving a high volume of requests for HUMBL core merchandise,” said HUMBL Studios lead Jennifer Edgerton. “This initial collection pairs high quality garments, with the HUMBL® brand logo on top of the Winter 2021 season’s HUMBL backdrop, called The Camo-Beach Collection.”HUMBL Studios will also be launching limited quantity HUMBL x Collections that will be recorded on the blockchain, through the use of a new technology called: Origin Assurance™....

Auriant Mining AB (publ.) (the “Company”) announces that it has been informed that Chairman of the Board of directors Peter Daresbury has sold 344,742 shares in the Company for SEK 1,514,655, due to personal circumstances brought about by the Covid-19 pandemic. Lord Daresbury continues to own 125,258 shares in the Company.For more information please contact:Danilo Lange, CEOTel: +7 495 109 02 82E-post: d.lange@auriant.comCompany name: Auriant Mining ABShort name: AURISIN-code: SE0001337213Website: www.auriant.comwww.facebook.com/AuriantMining/Auriant Mining AB (AUR) is a Swedish junior mining company focused on gold exploration and production in Russia, primarily in Zabaikalye and the Republics of Khakassia and Tyva. The company has currently four assets, including two operating mines (Tardan and Solococon), one early stage exploration...

Auriant Mining AB (publ.) (“Bolaget”) meddelar att det har informerats om att styrelseordförande Peter Daresbury har sålt 344 742 aktier i Bolaget för 1 514 655 SEK på grund av personliga omständigheter som orsakats av covid-19-pandemin. Lord Daresbury fortsätter att äga 125 258 aktier i Bolaget.För mer information, vänligen kontakta:Danilo Lange, VDTel: +7 495 109 02 82E-post: d.lange@auriant.comFöretagsnamn: Auriant Mining ABKortnamn: AURISIN-kod: SE0001337213Webbplats: www.auriant.comwww.facebook.com/AuriantMining/Auriant Mining AB (AUR) är ett svenskt gruvbolag med inriktning på prospektering och guldproduktion i Ryssland, främst i Zabaikalskiy regionen och republikerna Khakassia och Tyva. Bolaget har för närvarande fyra licenser, inklusive två gruvor i drift (Tardan och Solcocon), en prospekteringstillgång i ett tidigt...